Meghana Keshavan

1 week ago | statnews.com | Meghana Keshavan

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Morning. Today, we talk about Arkansas making a bold move to curb PBM power, analyze Trump’s executive order in regards to drug prices, and more. A daily pill from Eli Lilly helped patients with type 2 diabetes improve their blood sugar and shed weight, the company said this morning, late-stage results that could propel the next-generation treatment onto the market.

1 week ago | statnews.com | Meghana Keshavan

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Morning. Today, we discuss the latest executive order from President Trump, and also a surprisingly smooth meeting of CDC vaccine advisers. President Trump has issued a new executive order that takes aim at high drug prices and inefficiencies in Medicare. In a notable victory for the biotech and pharma industries, the order directs HHS Secretary Robert F.

1 week ago | statnews.com | Meghana Keshavan

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Morning. Today, we see President Trump’s tariff plan for pharma start to take shape, note the biotech job vacuum growing in the Boston area, and see more scrutiny of PBMs. From my colleague Elaine Chen: Johnson & Johnson reported first-quarter sales and earnings that beat Wall Street expectations this morning.

1 week ago | statnews.com | Meghana Keshavan

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Morning. Today, we discuss interesting new gene-editing data from Verve, see the NIH starting to convene advisory councils again, and more. Third Harmonic Bio, a company that has been developing treatments for inflammatory diseases, announced a plan to liquidate and dissolve itself.

2 weeks ago | statnews.com | Meghana Keshavan

Hey there. Today, we talk about the NIH’s database ban on researchers in countries including China and Russia, discuss the legality of the HHS firings, and more. The XBI fell more than 4% yesterday. The closely tracked index of biotech stocks is now down 13% since the announcement of President Trump’s tariff policy. It’s down 22% for the year.